NCT03664908View on ClinicalTrials.gov

Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

April 4, 2019

Study Completion Date

May 4, 2019

Conditions
Lupus Nephritis
Interventions
OTHER

Detection of circulating anti-GBM antibodies (using chemiluminescence method and indirect immunofluorescence (IIF) method).

biological detection of circulating anti-GBM antibodies (using chemiluminescence method and indirect immunofluorescence (IIF) method) in three serum samples groups, coming from SLE patients (having Lupus Nephritis or not) and in a control group.

Trial Locations (1)

Unknown

Damien JOLLY, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT03664908 - Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)? | Biotech Hunter | Biotech Hunter